000 01676nam  2200325za 4500
0019.813244
003CaOODSP
00520221107141511
007cr |||||||||||
008160504s2016    onc    #o    f000 0 eng d
020 |a978-0-660-04915-1
040 |aCaOODSP|beng
043 |an-cn---
0861 |aFA1-2016/1-4E-PDF
1101 |aCanada. |bOffice of the Auditor General.
24510|aDrug benefits - Veterans Affairs Canada |h[electronic resource].
260 |a[Ottawa] : |bOffice of the Auditor General of Canada, |cc2016.
300 |aiii, 21 p.
4901 |aReports of the Auditor General of Canada, |x1701-5413 ; |vSpring 2016, report 4
500 |aIssued also in French under title: Les prestations pharmaceutiques - Anciens Combattants Canada.
520 |a"This audit focused on whether Veterans Affairs Canada managed the drug component of its Health Care Benefits Program to contribute to the health of its veteran population by providing coverage for drugs based on evidence, using cost-effectiveness strategies, and monitoring the utilization of drugs covered."--Focus of the audit.
530 |aIssued also in printed form.
69207|2gccst|aVeterans
69207|2gccst|aBenefits
69207|2gccst|aPrescription drugs
69207|2gccst|aAudit
77508|tLes prestations pharmaceutiques - Anciens Combattants Canada |w(CaOODSP)9.813323
7760#|tDrug benefits - Veterans Affairs Canada.|w(CaOODSP)9.813309
830#0|aReports of the Auditor General of Canada,|x1701-5413 ; |vSpring 2016, report 4.|w(CaOODSP)9.811230
85640|qPDF|s621 KB|uhttps://publications.gc.ca/collections/collection_2016/bvg-oag/FA1-2016-1-4-eng.pdf